Dexcom Symposium

Driving Reduced Diabetes-Related Complications and Enhanced Therapy Optimisation Solutions
Monday, 15 September | 15:30 - 16:30 | Warsaw Hall

Continuous glucose monitoring (CGM) is shown to improve glycemic outcomes in T1D and T2D. This session will connect the dots between CGM usage and the reduction in acute complications such as DKA and SH, and long-term complications. Join us to explore why an early start with CGM and AID therapy supports better health outcomes and how Dexcom is continuing to innovate therapy optimisation to enable easier and streamlined care for you and your patients.


Moderator
Sufyan Hussain, MA, MB BChir, MRCP, PhD | United Kingdom


Consultant Physician in Diabetes & Endocrinology, Guy’s & St Thomas NHS Foundation Trust
Honorary Senior Clinical Lecturer, Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, Kings College London
Member, Board of Directors, International Diabetes Federation, Europe
View Full Bio
CGM Usage and Reduction in Micro- and Macrovascular Complications
Anne Peters, MD | United States


Director, USC Westside Center for Diabetes,
Professor, Keck School of Medicine of USC
Director, USC Clinical Diabetes Programs
View Full Bio
CGM in Action: Advancing Outcomes Along the Care Journey
Halis Akturk, MD | United States


Associate Professor of Medicine and Pediatrics, Barbara Davis Center for Diabetes, University of Colorado, USA
View Full Bio
Driving Innovation in Diabetes Management
Jake Leach | United States


President and Chief Operating Officer, Dexcom, Inc.
View Full Bio

Hot Topic Sessions


Join us later this week at our education sessions to discover how Dexcom is transforming diabetes care - one innovation at a time.

SESSION 1
Continuous Glucose Monitoring as the Catalyst for Behavioral Change Across People with Diabetes

Wednesday, 17 September 2025 | 14:00-14:30 CEST | Spotlight Stage

Discover how Continuous Glucose Monitoring (CGM) can transform diabetes care—not just by tracking glucose, but by empowering informed behavior change. In this 30-minute session three international experts will explore how insights from CGM data can support changes in food choices, increase activity, facilitate healthier self-care routines, and improve emotional well-being. The experts will discuss current challenges in diabetes management and explore how upcoming innovations can address those. Join us to see how CGM bridges the gap between knowing and doing in diabetes management.


Moderator
Nick Oliver, MBBS FRCP | United Kingdom


Imperial College London & Imperial College Healthcare NHS Trust

View Full Bio
Giesje Nefs, PhD | Netherlands

Assistant Professor, Radboud University Medical Centre
Senior Researcher, Tilburg University
Psychology Research Lead & Practising Psychologist, Diabeter and Diabeter Centrum Amsterdam

View Full Bio
Mohammed Al-Sofiani, MD, MSc, Associate Professor | Riyadh, Saudi Arabia

King Saudi University, Riyadh, Saudi Arabia, John Hopkins University, Baltimore, US

View Full Bio

SESSION 2
Demonstrating the Value of Dexcom CGM in Gestational Diabetes Mellitus

Friday, 19 September 2025 | 9:30-10:00 CEST | Spotlight Stage

Explore the pivotal role of continuous glucose monitoring (CGM) in managing gestational diabetes mellitus (GDM). Listen as the Investigators of the GRACE randomized control trial share how CGM improves glycemic outcomes and reduces adverse outcomes in women with GDM. Hear Prof Dr. Helen R. Murphy describes practical guidance and explore best practices for integrating CGM into your routine clinical workflow for woman with GDM. Attendees will gain both evidence-based updates and actionable insights to optimize CGM use in their own practice settings to personalize care during pregnancy.


How CGM Improve Outcomes for Mother and Child in CGM
Christian Göbl, MD, PhD | Austria


Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-maternal Medicine, Medical University of Vienna

View Full Bio
How CGM Improve Outcomes for Mother and Child in CGM
Tina Linder, MD, PhD | Austria


Medical University of Vienna, Department of Obstetrics and Gynecology, Division of Obstetrics and feto-maternal medicine

View Full Bio
Best Practices and Key Considerations for CGM in GDM
Helen Murphy MDBBChBAO, MD, FRACP | United Kingdom


Professor of Medicine (Diabetes & Antenatal Care), Bob Champion Research and Education (BCRE) Level 2, University of East Anglia
Honorary Consultant Physician, Norfolk & Norwich University Hospital NHS Foundation Trust

View Full Bio

In-Booth Presentations


Hear in-depth discussions from our Clinical Education experts on the many advancements Dexcom is making in the CGM space.

Tuesday, 16 September | Booth D1.01
12:45 - 13:00 CEST - Smart Sensors meet Smart Pens
14:15 - 14:30 CEST - From Data to Decisions: Advancing Behavioral Change through Glucose Monitoring

Wednesday, 17 September | Booth D1.01
13:30 - 13:45 CEST - Entering the Era of Therapy Optimisation with Dexcom

Questions?

If you have any questions regarding the event, please contact events@dexcom.com.
We look forward to seeing you in Vienna!